A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A pre-ablative thyroid-stimulating hormone with 30–70 mIU/L achieves better response to initial radioiodine remnant ablation in differentiated thyroid carcinoma patients ; volume:11 ; number:1 ; day:14 ; month:1 ; year:2021 ; pages:1-8 ; date:12.2021
Scientific reports ; 11, Heft 1 (14.1.2021), 1-8, 12.2021
- Urheber
-
Xiao, Juan
Yun, Canhua
Cao, Jingjia
Ding, Shouluan
Shao, Chunchun
Wang, Lina
Huang, Fengyan
Jia, Hongying
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-020-80015-8
- URN
-
urn:nbn:de:101:1-2021020823535353830663
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xiao, Juan
- Yun, Canhua
- Cao, Jingjia
- Ding, Shouluan
- Shao, Chunchun
- Wang, Lina
- Huang, Fengyan
- Jia, Hongying
- SpringerLink (Online service)
Ähnliche Objekte (12)
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Minimally invasive local ablative therapies in combination with radioiodine therapy in benign thyroid disease : preparation, feasibility and efficiency ; preliminary results
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
The EANM guideline on radioiodine therapy of benign thyroid disease
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
The role of miR-139-5p in radioiodine-resistant thyroid cancer
Heath-related quality of life in thyroid cancer patients following radioiodine ablation
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer
Biophysical studies of radioiodine metabolism during therapy of Autonomous Functioning Thyroid Nodule
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Minimally invasive local ablative therapies in combination with radioiodine therapy in benign thyroid disease : preparation, feasibility and efficiency ; preliminary results
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
The EANM guideline on radioiodine therapy of benign thyroid disease
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
The role of miR-139-5p in radioiodine-resistant thyroid cancer
Heath-related quality of life in thyroid cancer patients following radioiodine ablation
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer
Biophysical studies of radioiodine metabolism during therapy of Autonomous Functioning Thyroid Nodule
Radioiodine Thyroid Ablation in Graves′ Hyperthyroidism: Merits and Pitfalls
Minimally invasive local ablative therapies in combination with radioiodine therapy in benign thyroid disease : preparation, feasibility and efficiency ; preliminary results
Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer
The EANM guideline on radioiodine therapy of benign thyroid disease
Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status
Treatment of Radioiodine-Induced Xerostomia in Patients with Differenciated Thyroid Carcinoma
Acute Myeloid Leukemia after Low-Dose Radioiodine Therapy for Papillary Thyroid Carcinoma
The role of miR-139-5p in radioiodine-resistant thyroid cancer
Heath-related quality of life in thyroid cancer patients following radioiodine ablation
NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer
Lipid‐Peptide‐mRNA Nanoparticles Augment Radioiodine Uptake in Anaplastic Thyroid Cancer